Johnson & Johnson

The war in Iran is bringing uncertainty to the U.S. stock markets. 🇮🇷/🇺🇸

But what should we actually be worried about, and how do I think this whole situation will play out?

Shares of companies that manufacture combat drones, such as $ONDS, $AVAV, $UMAC, $RCAT or even $DPRO, are rising by several percent, some even by 10% or more.

It’s important to understand the perception and...
Read more

Johnson & Johnson $JNJ is considering the sale of its DePuy Synthes orthopedic division, which it originally planned to spin off as a standalone company. The potential value of the transaction is estimated at more than $20 billion.

Shares of $JNJ are up 4% after the results. The numbers look good, but my opinion hasn't changed and I still see the company as uninteresting and don't want to invest in it.

Do you still find $JNJ interesting?

📅 This week's key events!
The results season begins! Apart from inflation data, US banks, tech firms and consumer companies are the main ones coming to the fore.

📌 Monday
Market reaction to Trump's tariffs announcement.

Results before markets open:
Orkla $ORKLY - Scandinavian giant in food, household chemicals and consumer goods.

📈 Tuesday
US CPI Inflation - The monthly consumer...
Read more

📆 Weekly Investment Review: earnings season in full swing, complete with important data and geopolitics!

A mix of corporate results, economic statistics and geopolitical challenges await us this shortened week. Markets will react not only to the numbers, but also to speeches by central bankers and politicians.

🏦 Monday
Results before the markets open:
Goldman Sachs $GS - I'll be...
Read more

Shares of $JNJ fell 4% today after a US judge rejected Johnson & Johnson's proposal to settle tens of thousands of lawsuits for $10 billion. I don't have $JNJ stock in my portfolio and I certainly won't be buying it, because its growth is lousy and the business isn't doing very well either.

Does it make sense for anyone else to invest in $JNJ?

💡 Johnson & Johnson: $14.6 billion acquisition strengthens the pharmaceutical giant's position in the neurological drugs market 💊

Johnson & Johnson $JNJ, one of the biggest players in the healthcare industry, has once again shown that growth through strategic acquisitions is their forte.

The company announced last week the purchase of biopharmaceutical firm Intra-Cellular...
Read more

📅 This week's key market events! 🔍

This week is packed with results and events that can significantly impact the markets. Here's an overview of the most important ones for me. 👇

❌Monday:
Inauguration of Donald Trump - A very important political event.
Martin Luther King Day (stock markets closed) - A day of calm in the markets to prepare for earnings season.
WEF Forum in Davos -...
Read more

I see that $JNJstock is already down 9% this year and the stock hasn't risen much in the last 5 years. I've never been interested in this company and never invested in it, but I'm glad for that.

What do you think of $JNJ?

📅Key events of the upcoming week on the markets!

As earnings season gets underway there will be a lot to watch, last week $JPMBank kicked it off nicely by presenting beautiful results above analyst expectations. Let's see what the banks show us this week and they will also be joined by two tech giants along with the world's largest streaming platform. Here I bring you my...
Read more